EyeSense AG
EyeSense is a pioneering company in medical technology, focusing on innovative continuous glucose monitoring systems. With a mission to improve quality of life for those with chronic conditions, they develop precise, sustainable, and user-friendly health monitoring solutions. Their FiberSense platform extends beyond blood glucose measurement to include a broad spectrum of biometric data, aiming to revolutionize health monitoring and personalized medicine.
Industries
Nr. of Employees
small (1-50)
EyeSense AG
Stockstädter Str. 17, 63762 Großostheim, Germany
Patents
Method and apparatus for determining a smoothed data point within a stream of data points
US-11657120-B2
View DetailsDevice comprising a hydrogel having a glucose-binding protein and a ligand of the glucose-binding protein incorporated therein
US-10429380-B2
View Details
Method and apparatus for determining a smoothed data point within a stream of data points
US-11657120-B2
View DetailsDevice comprising a hydrogel having a glucose-binding protein and a ligand of the glucose-binding protein incorporated therein
US-10429380-B2
View DetailsProducts
Continuous optical fiber-based glucose monitoring system (in approval phase)
A wearable system using a fiber-optic sensor with a hydrogel-embedded biosensor chemistry to continuously measure glucose concentration in tissue fluid beneath the skin and wirelessly transmit real-time data to a smartphone app. The system is described as supporting up to four weeks wear and reusable electronic components; it is reported to be in regulatory approval processes and not yet a marketed device.
Continuous optical fiber-based glucose monitoring system (in approval phase)
A wearable system using a fiber-optic sensor with a hydrogel-embedded biosensor chemistry to continuously measure glucose concentration in tissue fluid beneath the skin and wirelessly transmit real-time data to a smartphone app. The system is described as supporting up to four weeks wear and reusable electronic components; it is reported to be in regulatory approval processes and not yet a marketed device.
Expertise Areas
- Continuous glucose monitoring
- Optical biosensing
- Hydrogel-based biosensor chemistry
- Clinical study execution and performance validation
Key Technologies
- Fiber-optic sensing
- Hydrogel-embedded biosensors
- Photometric biomarker detection
- Low-volume sensor dispensing (nanoliter-scale)
News & Updates
Development of initial prototypes and clinical trials
Progress in prototype development, clinical testing, and recognition through awards in medical technology.
Development of initial prototypes and clinical trials
Progress in prototype development, clinical testing, and recognition through awards in medical technology.